Attend a free virtual symposium on melanoma, Oct. 25

October 8, 2024 Providence Cancer Institute of Oregon

Please join us for “Living with Melanoma,” a virtual symposium presented by AIM at Melanoma in partnership with Providence Cancer Institute. This free online event is designed to educate and empower patients and care partners affected by melanoma.

You will hear from leading experts in the field of melanoma research and treatment, connect with others who share similar experiences and engage with community organizations for valuable resources. This event is open to patients, care partners, health care professionals and anyone interested in learning more about melanoma.

Date: Friday, Oct. 25, 2024

Time: 10:00 a.m. (PT) 11:00 a.m. (MT) 12:00 p.m. (CT) 1:00 p.m. (ET)

Format: Presented virtually

Register here

Presenters:

Chris Fountain, RN, OCN, Clinician – Researcher, Providence Cancer Institute

Brendan Curti, M.D., Medical Oncologist, Medical Director, Providence Melanoma Program, Providence Cancer Institute

Matthew Taylor, M.D., Medical Oncologist, Co-Medical Director, Providence Melanoma Program Providence Cancer Institute

Noa Curtis, MSW, LCSW, Oncology Social Worker, Providence Cancer Institute

Ann Garst Taylor, Director Community Engagement, AIM at Melanoma Foundation

About Providence Cancer Institute:

At Providence Cancer Institute, we see more than a cancer diagnosis, we see a path of healing and a way forward together. We are committed to supporting you every step of the way. We are proud to be recognized worldwide for our immunotherapy research and ground-breaking treatments. Our physicians are dedicated to providing the best personalized treatment options for optimal outcomes. Learn more.

Cancer survivor speaks with doctor he credits for saving his life

Cancer studies seek to harness the power of the immune system

Welcome to your journey for creating a healthier you

Attend a free virtual symposium on melanoma, Oct. 25

Previous Article

Next Article

Attend a free virtual symposium on melanoma, Oct. 25

Previous Article

Next Article

Other content in this Stream

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

The awards highlight Providence Swedish's consistency in following the American Heart Association's guidelines for care, treatment and improved outcomes in stroke and diabetes.

Menopause is a natural aging process for roughly half the population. Learn how to navigate the journey from perimenopause to menopause and beyond.

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Providence Community Cancer Screening Event

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

Sprawling multi-million dollar facility in Orange County is a one-stop location to access full-suite of women’s health, mother-baby services and more

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

At Providence, we recognize the importance of providing holistic care and comprehensive prenatal, labor and delivery, and postpartum support for Black birthing parents and babies.

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Learn the truth about endometriosis, including the symptoms, treatments and more in this comprehensive guide from Providence.

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.